Skip to main content
. Author manuscript; available in PMC: 2016 Nov 1.
Published in final edited form as: Environ Int. 2015 Aug 7;84:94–106. doi: 10.1016/j.envint.2015.07.003

Table 2. Creatinine-adjusted urinary phthalate metabolite concentrations in the Shanghai Men's and Shanghai Women's Health.

Phthalate Metabolite (μg/g creatinine)a Sample 1b Sample 2 Sample 3
% >LODc GM (5th, 95th percentile) % >LOD GM (5th, 95th percentile) % >LOD GM (5th, 95th percentile)
Males (N=48) (N=50) (N=50)
MBP 100 105 (34.1, 289) 100 66.1 (30.2, 173) 100 65.6 (24.8, 208)
MiBP 100 56.6 (23.2, 139) 100 45.6 (18.3, 114) 100 50.5 (19.3, 143)
MEP 100 9.98 (1.93, 163) 100 13.2 (2.14, 433) 100 10.6 (2.75, 49.0)
MBzP 65 0.566 (<LOD, 3.49) 70 0.450 (<LOD, 4.78) 60 0.407 (<LOD, 4.63)
MCNP 33 d (<LOD, 0.893) 46 d (<LOD, 0.891) 24 d (<LOD, 0.481)
MCOP 75 0.444 (<LOD, 4.37) 88 0.675 (<LOD, 3.12) 88 0.715 (0.220, 14.8)
MCPP 90 0.952 (<LOD, 3.17) 90 0.705 (<LOD, 2.56) 90 0.617 (0.213, 2.09)
MECPP 100 29.3 (12.0, 95.4) 100 26.0 (10.9, 123) 100 30.8 (12.8, 168)
MEHHP 100 21.0 (5.83, 110) 100 18.8 (7.01, 88.6) 100 21.3 (8.73, 99.9)
MEHP 92 4.24 (0.779, 33.2) 90 3.57 (0.663, 19.0) 96 3.40 (1.08, 13.3)
MEOHP 100 12.4 (3.67, 54.9) 100 11.2 (4.37, 53.8) 100 13.0 (5.08, 68.6)
ΣLMWPe 8.91 (2.72, 29.8) 7.40 (3.07, 27.0) 6.33 (2.56, 14.5)
ΣHMWP e 2.51 (0.884, 10.0) 2.15 (0.818, 9.41) 2.45 (0.976, 11.7)
ΣDEHPe 2.30 (0.859, 10.0) 2.05 (0.801, 9.36) 2.34 (0.942, 11.7)
ΣDBPe 7.58 (2.58, 17.1) 5.25 (2.37, 10.7) 5.46 (2.16, 14.0)
Females (N=49) (N=49) (N=50)
MBP 100 151 (48.2, 456) 100 88.9 (44.3, 149) 100 62.5 (26.6, 140)
MiBP 100 61.8 (13.8, 284) 100 49.4 (21.9, 138) 100 41.4 (15.0, 121)
MEP 100 28.5 (3.28, 783) 100 13.9 (2.35, 143) 98 20.0 (2.21, 146)
MBzP 84 1.13 (0.262, 9.30) 59 0.545 (<LOD, 2.81) 50 0.491 (<LOD, 2.65)
MCNP 37 d (<LOD, 0.703) 31 d (<LOD, 1.55) 28 d (<LOD, 0.554)
MCOP 33 d (<LOD, 2.30) 80 0.971 (<LOD, 9.76) 80 0.749 (<LOD, 2.89)
MCPP 90 1.31 (0.328, 4.49) 82 0.857 (<LOD, 3.47) 78 0.535 (<LOD, 1.69)
MECPP 100 32.3 (9.67, 235) 100 32.0 (11.1, 168) 100 31.9 (9.81, 222)
MEHHP 100 22.7 (7.51, 67.5) 100 21.9 (7.93, 101) 100 22.9 (7.26, 154)
MEHP 92 4.40 (0.913, 38.9) 82 3.39 (0.840, 20.9) 82 3.44 (0.581, 29.2)
MEOHP 100 14.5 (5.49, 45.3) 100 14.2 (5.79, 74.3) 100 14.4 (5.37, 97.1)
ΣLMWPe 14.4 (4.67, 67.7) 7.93 (4.64, 26.7) 7.26 (2.92, 12.5)
ΣHMWP e 2.70 (0.846, 11.9) 2.61 (0.973, 13.3) 2.59 (0.845, 17.1)
ΣDEHPe 2.55 (0.808, 11.9) 2.49 (0.946, 13.2) 2.51 (0.817, 17.0)
ΣDBPe 10.2 (3.23, 34.5) 6.42 (3.83, 12.1) 4.81 (1.82, 9.31)

Abbreviations: geometric mean (GM), limit of detection (LOD), mono-n-butyl phthalate (MBP), mono-isobutyl phthalate (MiBP), monoethyl phthalate (MEP), monobenzyl phthalate (MBzP), mono(carboxynonyl) phthalate (MCNP), mono(carboxyoctyl) phthalate (MCOP), mono(3-carboxypropyl) phthalate (MCPP), mono(2-ethyl-5-carboxypentyl) phthalate (MECPP), mono(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP), mono(2-ethylhexyl) phthalate (MEHP), mono(2-ethyl- 5-oxohexyl) phthalate (MEOHP), low molecular weight phthalate sum (ΣLMWP), high molecular weight phthalate sum (ΣHMWP), di(2-ethylhexyl) phthalate sum (ΣDEHP), dibutyl phthalate sum (ΣDBP).

a

Samples with creatinine concentration ≤20 or ≥275 mg/dL were excluded.

b

First samples were collected during 2003-2004 for men and 1998-2002 for women.

c

LODs (in μg/L) are MBP: 0.4, MiBP: 0.2, MEP: 0.4, MBzP: 0.2, MCNP: 0.2, MCOP: 0.2, MCPP: 0.2, MECPP: 0.2, MEHHP: 0.2, MEHP: 0.5, MEOHP: 0.2.

d

GM not calculated (>50% of samples below the LOD).

e

Molar sums; units are nanomoles per gram creatinine.